The 10th Annual Advanced Curriculum for Multiple Sclerosis, chaired by Dr. Fred D. Lublin, is an innovative medical education program that provides clinicians with recent information relative to all aspects of the multiple sclerosis disease spectrum. This comprehensive curriculum will utilize interactive and engaging formats to deliver practical information regarding the care of patients with MS that can be applied in practice. Topics for this CME/CE course include diagnosis, biomarkers, and monitoring, current and emerging MS therapeutics, shared decision making, management of the MS patient, and advances in MS centers.
Neurologists, MS specialists, fellows, residents, nurses, pharmacists, and other healthcare professionals involved in the management of patients with multiple sclerosis.
This program is supported by independent educational grants from EMD Serono; Novartis Pharmaceuticals Corporation; Sanofi and TG Therapeutics, Inc.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Oceana Ballroom AB
Hilton West Palm Beach
600 Okeechobee Blvd
West Palm Beach, FL 33401
For all CE inquiries or special needs, please contact admin@academiccme.com.
| 7:15am - 7:30am | Welcome and Introductions – Fred D. Lublin, MD |
| 7:30am - 8:00am | McDonald Criteria 2024 – What’s New & How to Implement? Faculty: Joseph Berger, MD |
| 8:00am - 8:20am | Advanced MRI Studies, Specificity and Prognosis Faculty: Daniel Reich, MD, PhD |
| 8:20am - 8:40am | The Role of the Optic Nerve in Diagnosing MS – Clinical, Neurophysiologic & OCT Faculty: Fiona Costello, MD |
| 8:40am - 9:00am | Biomarker/Immune Profiling Update – Where Are We Now? Faculty: Peter Calabresi, MD |
| 9:00am - 9:20am | Discussion of Clinical Courses - Prodrome, RIS, CIS, RRMS, Progressive Disease, RAW, PIRA Faculty: Fred D. Lublin, MD |
| 9:20am - 9:30am | Break |
| 9:30am - 10:15am | Clinical Update on Anti-CD20 Therapeutics Faculty: Mark Freedman, MD |
| 10:15am-10:45am | Oral Meds Faculty: Clyde Markowitz, MD |
| 10:45am-11:15am | BTK Faculty: Amit Bar-Or, MD |
| 11:15am-11:45am | Review of the Overall Treatment Strategy with Current Agents Faculty: Stephen Krieger, MD |
| 11:45am - 12:15pm | What’s Exciting in the Pipeline? Faculty: Aaron Miller, MD |
| 12:15pm-12:45pm | Lunch Best Practices in Contract Negotiation: Knowing Your Worth as an MS Specialist |
| 12:45pm - 1:30pm | The Potential Utility of BTK Therapeutics to Manage Patients with Secondary Progressive Multiple Sclerosis Faculty: Benjamin Greenberg, MD |
| 1:30pm – 2:00pm | Debate – Does a Virus Cause MS? Faculty: Benjamin Greenberg, MD (Pro) & Patricia Coyle, MD (Con) |
| 2:00pm – 2:30pm | Cell Therapies to Treat MS Faculty: Jeffrey Cohen, MD |
| 2:30pm – 3:00pm | Symptom Management Faculty: Daniel Ontaneda, MD, PhD |
| 3:00pm – 3:30pm | Break |
| 3:30pm - 4:00pm | Healthcare Disparity Faculty: Robert Naismith, MD |
| 4:00pm - 4:15pm | Family Planning Faculty: Amy Perrin Ross, APN, MSN, CNRN, MSCN |
| 4:15pm - 4:30pm | Patient Education, Shared Decision Making and Tools Faculty: Amy Perrin Ross, APN, MSN, CNRN, MSCN |
| 4:30pm - 5:00pm | Artificial Intelligence in the Future of MS Care Faculty: Erin Longbrake, MD, PhD |
| 5:00pm – 6:00pm | Meeting Adjourn |
| 7:15am - 7:30am | Welcome and Introductions – Fred D. Lublin, MD |
| 7:30am - 8:00am | McDonald Criteria 2024 – What’s New & How to Implement? Faculty: Joseph Berger, MD |
| 8:00am - 8:20am | Advanced MRI Studies, Specificity and Prognosis Faculty: Daniel Reich, MD, PhD |
| 8:20am - 8:40am | The Role of the Optic Nerve in Diagnosing MS – Clinical, Neurophysiologic & OCT Faculty: Fiona Costello, MD |
| 8:40am - 9:00am | Biomarker/Immune Profiling Update – Where Are We Now? Faculty: Peter Calabresi, MD |
| 9:00am - 9:20am | Discussion of Clinical Courses - Prodrome, RIS, CIS, RRMS, Progressive Disease, RAW, PIRA Faculty: Fred D. Lublin, MD |
| 9:20am - 9:30am | Break |
| 9:30am - 10:15am | Clinical Update on Anti-CD20 Therapeutics Faculty: Mark Freedman, MD |
| 10:15am-10:45am | Oral Meds Faculty: Clyde Markowitz, MD |
| 10:45am-11:15am | BTK Faculty: Amit Bar-Or, MD |
| 11:15am-11:45am | Review of the Overall Treatment Strategy with Current Agents Faculty: Stephen Krieger, MD |
| 11:45am - 12:15pm | What’s Exciting in the Pipeline? Faculty: Aaron Miller, MD |
| 12:15pm-12:45pm | Lunch Best Practices in Contract Negotiation: Knowing Your Worth as an MS Specialist |
| 12:45pm - 1:30pm | The Potential Utility of BTK Therapeutics to Manage Patients with Secondary Progressive Multiple Sclerosis Faculty: Benjamin Greenberg, MD |
| 1:30pm – 2:00pm | Debate – Does a Virus Cause MS? Faculty: Benjamin Greenberg, MD (Pro) & Patricia Coyle, MD (Con) |
| 2:00pm – 2:30pm | Cell Therapies to Treat MS Faculty: Jeffrey Cohen, MD |
| 2:30pm – 3:00pm | Symptom Management Faculty: Daniel Ontaneda, MD, PhD |
| 3:00pm – 3:30pm | Break |
| 3:30pm - 4:00pm | Healthcare Disparity Faculty: Robert Naismith, MD |
| 4:00pm - 4:15pm | Family Planning Faculty: Amy Perrin Ross, APN, MSN, CNRN, MSCN |
| 4:15pm - 4:30pm | Patient Education, Shared Decision Making and Tools Faculty: Amy Perrin Ross, APN, MSN, CNRN, MSCN |
| 4:30pm - 5:00pm | Artificial Intelligence in the Future of MS Care Faculty: Erin Longbrake, MD, PhD |
| 5:00pm – 6:00pm | Meeting Adjourn |
*All timings are approximate and in Eastern Standard Time
*Agenda subject to change
811 S. Orleans Ave. Tampa, Fl 33606
